Oki M, et al. - Researchers assessed the efficacy of airway stenting for patients with airway stenosis resulting from small-cell lung cancer (SCLC), via a retrospective review. Of 21 patients eligible for analysis, 12 were chemoradiotherapy-naïve. Supplemental oxygen was reduced after the procedure in 11 out of 12 patients (92%) who had previously required it. Tumour-specific therapy was administered to 14 patients (67%) after the procedure. The reported median post-procedural survival was 47 days (range, 5-617 days). The following were found to be associated with longer survival in SCLC patients with airway stenting: performance of post-procedural tumour-specific therapy, low serum lactate dehydrogenase levels, and either tracheal or bronchial stenosis.